vortioxetine and empagliflozin

vortioxetine has been researched along with empagliflozin* in 1 studies

Other Studies

1 other study(ies) available for vortioxetine and empagliflozin

Article	Year
2015 new drug update. The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, 2015, Volume: 30, Issue:4 Six new drugs approved within the last two years, which are used for medical problems often experienced by the elderly, have been selected for consideration in this review. The uses and most important properties of these agents are discussed, and a rating for each new drug is determined using the New Drug Comparison Rating system developed by the author. Advantages, disadvantages, and other important information regarding the new drug are identified and used as the basis for determining the rating. The drugs include two antidiabetic agents, one bronchodilator, one antidepressant, one for erectile dysfunction, and one for menopause-associated conditions. Topics: Benzhydryl Compounds; Drug Approval; Estrogens, Conjugated (USP); Glucagon-Like Peptide 1; Glucosides; Humans; Indoles; Piperazines; Pyrimidines; Quinuclidines; Sulfides; Vortioxetine	2015

Article

Year

2015 new drug update.

The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists, 2015, Volume: 30, Issue:4

Six new drugs approved within the last two years, which are used for medical problems often experienced by the elderly, have been selected for consideration in this review. The uses and most important properties of these agents are discussed, and a rating for each new drug is determined using the New Drug Comparison Rating system developed by the author. Advantages, disadvantages, and other important information regarding the new drug are identified and used as the basis for determining the rating. The drugs include two antidiabetic agents, one bronchodilator, one antidepressant, one for erectile dysfunction, and one for menopause-associated conditions.

Topics: Benzhydryl Compounds; Drug Approval; Estrogens, Conjugated (USP); Glucagon-Like Peptide 1; Glucosides; Humans; Indoles; Piperazines; Pyrimidines; Quinuclidines; Sulfides; Vortioxetine

2015